Brain functional imaging study of possible effects of substance Preceptor antagonist on alcohol craving
Brain functional imaging study of possible effects of substance Preceptor antagonist on alcohol craving
批准号:
22659212
负责人:
OKUBO Yoshiro
金额:
$2.1万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012
中文摘要
神经激肽-1(NK1)受体是P物质(SP)的同源受体,在人的伏隔核(NAC)中高表达,并被认为在NAC的正向奖赏加工中起作用。因此,我们进行了一项功能磁共振成像(FMRI)研究,以评估NK1受体拮抗剂对人类奖赏加工的影响。健康的成年人参加了一系列的功能磁共振研究,服用安慰剂或NK1受体拮抗剂。功能磁共振成像显示,与安慰剂治疗相比,与安慰剂治疗相比,在预期恢复期间,NAC中的血氧水平依赖信号显著减少。这些结果表明,SP/NK1受体系统参与了重词加工,并在奖赏环路中起到加强正价或酒精渴求的作用。
英文摘要
Neurokinin-1 (NK1) receptor, the cognate receptor for substance P (SP), is highly expressed in the nucleus accumbens (NAc) and has been hypothesized to have a role in positive reward processing in the NAc in humans. Therefore, we conducted a functional MRI (fMRI) study to assess the effects of an NK1 receptor antagonist on human reward processing. Healthy adults participated in series of an fMRI study, taking either a placebo or the NK1 receptor antagonist aprepitant. fMRI showed significant decrease in blood oxygenation-level-dependent signals in the NAc during gain anticipation with the aprepitant treatment compared to the placebo treatment. These results suggest that SP/NK1 receptor system is involved in reword processing and plays a role in accentuating positive valence or alcohol craving in the reward circuit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
講演紹介「PETを用いた新規抗精神病薬blonanserinの評価」
讲座简介:《利用PET评价新型抗精神病药布南色林》
DOI:
--
发表时间:
2011
期刊:
臨床精神薬理
影响因子:
--
作者:
[Abe-Mukumoto S, Mori T, Sakabe JI, Fukamachi S, Nakamura M, Kabashima K, Tokura Y, 舘野周]
通讯作者:
舘野周
Effect of caffeine and placebo on cerebral response to vocal emotional sounds and working memoryy:An fMRI study
咖啡因和安慰剂对大脑对声音情绪声音和工作记忆的反应的影响:功能磁共振成像研究
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Koeda M, Nakano Y, Ikeda Y, Tateno A, Kim WC, Takahashi H, Suzuki H, Matsuura M, Okubo Y]
通讯作者:
Okubo Y
Paliperidone徐放錠の脳内動態特性
帕潘立酮缓释片的脑动力学特征
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[花元克巳, 川辺睦, 迫田晃弘, 片岡隆浩, 岡田麻里, 山岡聖典, 大久保善朗]
通讯作者:
大久保善朗
DOI:
10.1186/1471-244x-12-205
发表时间:
2012-11-22
期刊:
BMC psychiatry
影响因子:
4.4
作者:
[Omori A, Tateno A, Ideno T, Takahashi H, Kawashima Y, Takemura K, Okubo Y]
通讯作者:
Okubo Y
PET所見を中心にしたパリペリドン徐放錠の薬理学的考察
重点关注 PET 结果的帕潘立酮缓释片的药理学考虑
DOI:
--
发表时间:
2011
期刊:
精神科
影响因子:
--
作者:
[Shiba N, et al, 大久保善朗]
通讯作者:
大久保善朗
共 31 条
Molecular imaging of altered dopamine transmission in patients with schizophrenia
-
批准号:19390308
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2007
-
负责人:OKUBO Yoshiro
-
依托单位:
Morphological and functional neuroimaging studies on progressive changes in schizophrenia.
-
批准号:15390348
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.9万
-
财政年份:2003
-
负责人:OKUBO Yoshiro
-
依托单位:
PET study of 5-HT1A and GABA receptors in temporal lobe epilepsy.
-
批准号:13670988
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2001
-
负责人:OKUBO Yoshiro
-
依托单位:
Development of three-dimensional atlas of neural transmission and its application for new psychotropic medication
-
批准号:11557070
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:OKUBO Yoshiro
-
依托单位:
PET study of dopamine D1 and D2 receptors in epilepsy and epileptic psychosis.
-
批准号:11670931
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:OKUBO Yoshiro
-
依托单位:
PET receptor studies on scgizophrenia and extrapyramidal side effects.
-
批准号:07671053
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:OKUBO Yoshiro
-
依托单位:
海外基金